Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity.

Cell Death Dis 2018 08 30;9(9):894. Epub 2018 Aug 30.

Leicester Cancer Research Centre, University of Leicester, Leicester, LE2 7LX, UK.

Improving early detection of colorectal cancer (CRC) is a key public health priority as adenomas and stage I cancer can be treated with minimally invasive procedures. Population screening strategies based on detection of occult blood in the feces have contributed to enhance detection rates of localized disease, but new approaches based on genetic analyses able to increase specificity and sensitivity could provide additional advantages compared to current screening methodologies. Recently, circulating cell-free DNA (cfDNA) has received much attention as a cancer biomarker for its ability to monitor the progression of advanced disease, predict tumor recurrence and reflect the complex genetic heterogeneity of cancers. Here, we tested whether analysis of cfDNA is a viable tool to enhance detection of colon adenomas. To address this, we assessed a cohort of patients with adenomas and healthy controls using droplet digital PCR (ddPCR) and mutation-specific assays targeted to trunk mutations. Additionally, we performed multiregional, targeted next-generation sequencing (NGS) of adenomas and unmasked extensive heterogeneity, affecting known drivers such as APC, KRAS and mismatch repair (MMR) genes. However, tumor-related mutations were undetectable in patients' plasma. Finally, we employed a preclinical mouse model of Apc-driven intestinal adenomas and confirmed the inability to identify tumor-related alterations via cfDNA, despite the enhanced disease burden displayed by this experimental cancer model. Therefore, we conclude that benign colon lesions display extensive genetic heterogeneity, that they are not prone to release DNA into the circulation and are unlikely to be reliably detected with liquid biopsies, at least with the current technologies.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-018-0934-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117318PMC
August 2018
32 Reads
5.014 Impact Factor

Publication Analysis

Top Keywords

genetic heterogeneity
12
enhance detection
8
adenomas
6
pcr ddpcr
4
digital pcr
4
mutation-specific assays
4
ddpcr mutation-specific
4
droplet digital
4
patients adenomas
4
cohort patients
4
adenomas healthy
4
healthy controls
4
controls droplet
4
assays targeted
4
targeted trunk
4
sequencing ngs
4
next-generation sequencing
4
ngs adenomas
4
adenomas unmasked
4
unmasked extensive
4

Similar Publications